Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human β2-glycoprotein I

Jacob George, Miri Blank, Boris Gilburd, Maya Hojnik, Boris Shenkman, Iiia Tamarin, David Varon, Eiji Matsuura, Takao Koike, Yehuda Shoenfeld

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

β2-Glycoprotein I (β2GPI) is a 50 kDa molecule proposed as a principal target of 'autoimmune' antiphospholipid antibodies (aPL). We have used deleted mutants (DM) representing different domains of β2GPI (I-IV, IV-V and V) for immunization of naive mice and studied the characteristics of the respective murine IgG preparations in comparison with affinity-purified IgG from two patients with primary antiphospholipid syndrome. Immunization with β2GPI and with the DM produced anti-β2GPI antibodies, part of which reacted with negatively charged phospholipids (PL), whereas reactivity with cardiolipin was evident only in the IgG from mice immunized with β2GPI. These results are consistent with the presumption that aPL are induced following the in vivo association of β2GPI (used for immunization) with resident negatively charged PL. Accordingly, DM which either lack the PL binding site or aPL attachment locus did not elicit, upon immunization, antibodies reactive with PL. Further, murine anti-β2GPI IgG and human 'autoimmune' aPL were similar, albeit not identical, in terms of DM requirement for PL binding and charge dependency. Murine antibodies and human aPL, regardless of their binding characteristics, were found to bind significantly to platelets upon their activation with thrombin and to promote platelet activation. The results of the current study emphasize the dissimilarities between human 'autoimmune' aPL and murine anti-β2GPI. Thus, anti-β2GPI antibodies to different DM as well as human aPL are capable of binding and activating human platelets provided β2GPI is present.

Original languageEnglish
Pages (from-to)913-921
Number of pages9
JournalInternational Immunology
Volume9
Issue number6
DOIs
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Antiphospholipid Antibodies
Glycoproteins
Antibodies
Phospholipids
Immunization
Immunoglobulin G
Blood Platelets
Cardiolipins
Antiphospholipid Syndrome
Platelet Activation
Thrombin
Binding Sites

Keywords

  • β-glycoprotein I
  • Antibodies
  • Antiphospholipid syndrome
  • Autoimmunity
  • Platelets

ASJC Scopus subject areas

  • Immunology

Cite this

Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human β2-glycoprotein I. / George, Jacob; Blank, Miri; Gilburd, Boris; Hojnik, Maya; Shenkman, Boris; Tamarin, Iiia; Varon, David; Matsuura, Eiji; Koike, Takao; Shoenfeld, Yehuda.

In: International Immunology, Vol. 9, No. 6, 1997, p. 913-921.

Research output: Contribution to journalArticle

George, J, Blank, M, Gilburd, B, Hojnik, M, Shenkman, B, Tamarin, I, Varon, D, Matsuura, E, Koike, T & Shoenfeld, Y 1997, 'Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human β2-glycoprotein I', International Immunology, vol. 9, no. 6, pp. 913-921. https://doi.org/10.1093/intimm/9.6.913
George, Jacob ; Blank, Miri ; Gilburd, Boris ; Hojnik, Maya ; Shenkman, Boris ; Tamarin, Iiia ; Varon, David ; Matsuura, Eiji ; Koike, Takao ; Shoenfeld, Yehuda. / Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human β2-glycoprotein I. In: International Immunology. 1997 ; Vol. 9, No. 6. pp. 913-921.
@article{07b2bf207e9a4e07bd6c32d71a240c6d,
title = "Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human β2-glycoprotein I",
abstract = "β2-Glycoprotein I (β2GPI) is a 50 kDa molecule proposed as a principal target of 'autoimmune' antiphospholipid antibodies (aPL). We have used deleted mutants (DM) representing different domains of β2GPI (I-IV, IV-V and V) for immunization of naive mice and studied the characteristics of the respective murine IgG preparations in comparison with affinity-purified IgG from two patients with primary antiphospholipid syndrome. Immunization with β2GPI and with the DM produced anti-β2GPI antibodies, part of which reacted with negatively charged phospholipids (PL), whereas reactivity with cardiolipin was evident only in the IgG from mice immunized with β2GPI. These results are consistent with the presumption that aPL are induced following the in vivo association of β2GPI (used for immunization) with resident negatively charged PL. Accordingly, DM which either lack the PL binding site or aPL attachment locus did not elicit, upon immunization, antibodies reactive with PL. Further, murine anti-β2GPI IgG and human 'autoimmune' aPL were similar, albeit not identical, in terms of DM requirement for PL binding and charge dependency. Murine antibodies and human aPL, regardless of their binding characteristics, were found to bind significantly to platelets upon their activation with thrombin and to promote platelet activation. The results of the current study emphasize the dissimilarities between human 'autoimmune' aPL and murine anti-β2GPI. Thus, anti-β2GPI antibodies to different DM as well as human aPL are capable of binding and activating human platelets provided β2GPI is present.",
keywords = "β-glycoprotein I, Antibodies, Antiphospholipid syndrome, Autoimmunity, Platelets",
author = "Jacob George and Miri Blank and Boris Gilburd and Maya Hojnik and Boris Shenkman and Iiia Tamarin and David Varon and Eiji Matsuura and Takao Koike and Yehuda Shoenfeld",
year = "1997",
doi = "10.1093/intimm/9.6.913",
language = "English",
volume = "9",
pages = "913--921",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human β2-glycoprotein I

AU - George, Jacob

AU - Blank, Miri

AU - Gilburd, Boris

AU - Hojnik, Maya

AU - Shenkman, Boris

AU - Tamarin, Iiia

AU - Varon, David

AU - Matsuura, Eiji

AU - Koike, Takao

AU - Shoenfeld, Yehuda

PY - 1997

Y1 - 1997

N2 - β2-Glycoprotein I (β2GPI) is a 50 kDa molecule proposed as a principal target of 'autoimmune' antiphospholipid antibodies (aPL). We have used deleted mutants (DM) representing different domains of β2GPI (I-IV, IV-V and V) for immunization of naive mice and studied the characteristics of the respective murine IgG preparations in comparison with affinity-purified IgG from two patients with primary antiphospholipid syndrome. Immunization with β2GPI and with the DM produced anti-β2GPI antibodies, part of which reacted with negatively charged phospholipids (PL), whereas reactivity with cardiolipin was evident only in the IgG from mice immunized with β2GPI. These results are consistent with the presumption that aPL are induced following the in vivo association of β2GPI (used for immunization) with resident negatively charged PL. Accordingly, DM which either lack the PL binding site or aPL attachment locus did not elicit, upon immunization, antibodies reactive with PL. Further, murine anti-β2GPI IgG and human 'autoimmune' aPL were similar, albeit not identical, in terms of DM requirement for PL binding and charge dependency. Murine antibodies and human aPL, regardless of their binding characteristics, were found to bind significantly to platelets upon their activation with thrombin and to promote platelet activation. The results of the current study emphasize the dissimilarities between human 'autoimmune' aPL and murine anti-β2GPI. Thus, anti-β2GPI antibodies to different DM as well as human aPL are capable of binding and activating human platelets provided β2GPI is present.

AB - β2-Glycoprotein I (β2GPI) is a 50 kDa molecule proposed as a principal target of 'autoimmune' antiphospholipid antibodies (aPL). We have used deleted mutants (DM) representing different domains of β2GPI (I-IV, IV-V and V) for immunization of naive mice and studied the characteristics of the respective murine IgG preparations in comparison with affinity-purified IgG from two patients with primary antiphospholipid syndrome. Immunization with β2GPI and with the DM produced anti-β2GPI antibodies, part of which reacted with negatively charged phospholipids (PL), whereas reactivity with cardiolipin was evident only in the IgG from mice immunized with β2GPI. These results are consistent with the presumption that aPL are induced following the in vivo association of β2GPI (used for immunization) with resident negatively charged PL. Accordingly, DM which either lack the PL binding site or aPL attachment locus did not elicit, upon immunization, antibodies reactive with PL. Further, murine anti-β2GPI IgG and human 'autoimmune' aPL were similar, albeit not identical, in terms of DM requirement for PL binding and charge dependency. Murine antibodies and human aPL, regardless of their binding characteristics, were found to bind significantly to platelets upon their activation with thrombin and to promote platelet activation. The results of the current study emphasize the dissimilarities between human 'autoimmune' aPL and murine anti-β2GPI. Thus, anti-β2GPI antibodies to different DM as well as human aPL are capable of binding and activating human platelets provided β2GPI is present.

KW - β-glycoprotein I

KW - Antibodies

KW - Antiphospholipid syndrome

KW - Autoimmunity

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=8244226657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8244226657&partnerID=8YFLogxK

U2 - 10.1093/intimm/9.6.913

DO - 10.1093/intimm/9.6.913

M3 - Article

C2 - 9199975

AN - SCOPUS:8244226657

VL - 9

SP - 913

EP - 921

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 6

ER -